[A double-blind trial of nicotine patches in smoking cessation]
- PMID: 1736456
[A double-blind trial of nicotine patches in smoking cessation]
Abstract
The use of nicotine chewing gum combined with psychological support improves the success rate in stopping smoking. We studied the safety and efficacy of a transdermal nicotine patch in stopping smoking. We conducted a double-blind randomized study comparing the effect of a 16-hour nicotine patch (15 +/- 3.5 mg of nicotine in 16 hours) with those of a placebo patch. Of the 289 smokers (207 women and 82 men) enrolled in the study, 145 were treated with nicotine patches and 144 with placebo patches for 16 weeks. The rates of sustained abstinence were significantly better with active treatment than with the placebo: 53, 41, 24 and 17% of those in the nicotine-patch group were abstinent after 6, 12, 26, and 52 weeks, respectively, as compared with 17, 10, 5 and 4% of those in the placebo-patch group (p less than 0.0001). Only two subjects with the nicotine patch and one with the placebo patch withdrew from the study because of side effects. The nicotine skin patch proved to be safe and effective, as demonstrated by a higher rate of abstinence than with the placebo.
Similar articles
-
Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.Br J Gen Pract. 1996 Mar;46(404):145-8. Br J Gen Pract. 1996. PMID: 8731618 Free PMC article. Clinical Trial.
-
Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.Clin Ther. 2009 Sep;31(9):1957-65. doi: 10.1016/j.clinthera.2009.08.029. Clin Ther. 2009. PMID: 19843485
-
Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.Prev Med. 1995 Jan;24(1):41-7. doi: 10.1006/pmed.1995.1006. Prev Med. 1995. PMID: 7740014 Clinical Trial.
-
Transdermal nicotine replacement and smoking cessation.Am Fam Physician. 1992 Jun;45(6):2595-602. Am Fam Physician. 1992. PMID: 1595510 Review.
-
Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.Arch Fam Med. 1993 Apr;2(4):417-23. doi: 10.1001/archfami.2.4.417. Arch Fam Med. 1993. PMID: 8130921 Review.
Cited by
-
Interventions for preventing weight gain after smoking cessation.Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD006219. doi: 10.1002/14651858.CD006219.pub4. Cochrane Database Syst Rev. 2021. PMID: 34611902 Free PMC article.
-
Nicotine replacement therapy versus control for smoking cessation.Cochrane Database Syst Rev. 2018 May 31;5(5):CD000146. doi: 10.1002/14651858.CD000146.pub5. Cochrane Database Syst Rev. 2018. PMID: 29852054 Free PMC article.
-
A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch.Drug Saf. 1998 Apr;18(4):297-308. doi: 10.2165/00002018-199818040-00005. Drug Saf. 1998. PMID: 9565740
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical